Published in Stroke on March 10, 2011
A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial. Lancet Neurol (2012) 1.95
A survey study to validate a four phases development model for integrated care in the Netherlands. BMC Health Serv Res (2013) 0.91
Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care. Implement Sci (2014) 0.86
Can online benchmarking increase rates of thrombolysis? Data from the Austrian stroke unit registry. J Neurol (2013) 0.86
Mild stroke and rapidly improving symptoms: it's not always a happy ending. Stroke (2011) 0.85
In cold blood: intraarteral cold infusions for selective brain cooling in stroke. J Cereb Blood Flow Metab (2014) 0.84
Stroke warning campaigns: delivering better patient outcomes? A systematic review. Patient Relat Outcome Meas (2015) 0.84
Measuring Quality Improvement in Acute Ischemic Stroke Care: Interrupted Time Series Analysis of Door-to-Needle Time. Cerebrovasc Dis Extra (2014) 0.83
Isolation of inflammatory cells from rat brain tissue after stroke. Exp Transl Stroke Med (2012) 0.82
Factors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China. PLoS One (2015) 0.81
Thrombolysis in acute ischemic stroke: a simulation study to improve pre- and in-hospital delays in community hospitals. PLoS One (2013) 0.81
Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid endarterectomy. Neurosurgery (2014) 0.79
Stroke Ready Intervention: Community Engagement to Decrease Prehospital Delay. J Am Heart Assoc (2016) 0.79
Generalization of the Right Acute Stroke Prevention Strategies in Reducing in-Hospital Delays. PLoS One (2016) 0.79
Letter by Lahr et al regarding article, "Promoting thrombolysis in acute ischemic stroke". Stroke (2011) 0.75
The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT. BMC Neurol (2015) 0.75
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Silent brain infarcts: a systematic review. Lancet Neurol (2007) 5.76
A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med (1991) 5.69
Evidence for the impact of quality improvement collaboratives: systematic review. BMJ (2008) 5.49
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke (2003) 4.78
Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation (2004) 4.45
External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA (2005) 4.38
Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89
Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (2005) 3.34
Incidence and prognosis of transient neurological attacks. JAMA (2007) 3.21
Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 3.17
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet (2012) 3.14
Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2002) 3.00
Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care (2002) 2.98
Atherosclerosis and risk for dementia. Ann Neurol (2007) 2.97
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol (2005) 2.80
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol (2009) 2.78
High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation (2006) 2.69
Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke (2006) 2.63
Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol (2009) 2.55
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation (2005) 2.48
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke (2008) 2.48
Serum uric acid levels and the risk of Parkinson disease. Ann Neurol (2005) 2.47
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol (2002) 2.30
Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke (2007) 2.27
Plasma clusterin and the risk of Alzheimer disease. JAMA (2011) 2.19
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment? Crit Care Med (2009) 2.16
Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2003) 2.10
A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med (2003) 2.04
Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke (2006) 1.99
Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future research. Lancet Neurol (2013) 1.94
Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry (2006) 1.85
Sixteen-detector row CT angiography of carotid arteries: comparison of different volumes of contrast material with and without a bolus chaser. Radiology (2005) 1.78
Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients. Hypertension (2008) 1.76
A four phase development model for integrated care services in the Netherlands. BMC Health Serv Res (2009) 1.75
Inadequate acoustical temporal bone window in patients with a transient ischemic attack or minor stroke: role of skull thickness and bone density. Ultrasound Med Biol (2008) 1.73
Performance improvement based on integrated quality management models: what evidence do we have? A systematic literature review. Int J Qual Health Care (2007) 1.72
Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol (2012) 1.72
A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project. Clin Trials (2010) 1.69
Predicting intracranial traumatic findings on computed tomography in patients with minor head injury: the CHIP prediction rule. Ann Intern Med (2007) 1.65
High von Willebrand factor levels increase the risk of stroke: the Rotterdam study. Stroke (2010) 1.64
Methylenetetrahydrofolate reductase C677T genotype and PD. Ann Neurol (2005) 1.64
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med (2009) 1.61
A quality management model for integrated care: results of a Delphi and Concept Mapping study. Int J Qual Health Care (2008) 1.60
Factors influencing intracranial pressure monitoring guideline compliance and outcome after severe traumatic brain injury. Crit Care Med (2012) 1.59
Clinical factors associated with outcome in chronic subdural hematoma: a retrospective cohort study of patients on preoperative corticosteroid therapy. Neurosurgery (2012) 1.59
The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace (2010) 1.59
Different classifications of nocturnal blood pressure dipping affect the prevalence of dippers and nondippers and the relation with target-organ damage. J Hypertens (2008) 1.57
Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. Ann Neurol (2012) 1.55
Endothelial activation in lacunar stroke subtypes. Stroke (2010) 1.55
Brain microbleeds are associated with ambulatory blood pressure levels in a hypertensive population. Hypertension (2007) 1.55
IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics (2010) 1.53
MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials (2014) 1.51
Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach. Cost Eff Resour Alloc (2010) 1.51
Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study. J Neurotrauma (2013) 1.51
Interventions to improve team effectiveness: a systematic review. Health Policy (2009) 1.50
Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ (2005) 1.50
A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain (2010) 1.49
Predicting asthma in preschool children with asthma-like symptoms: validating and updating the PIAMA risk score. J Allergy Clin Immunol (2013) 1.49
Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol (2006) 1.49
Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke (2007) 1.47
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke (2009) 1.47
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest (2011) 1.46
Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis (2009) 1.46
Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke. Cerebrovasc Dis (2013) 1.46
Real-life costs and effects of an implementation program to increase thrombolysis in stroke. Neurology (2012) 1.45
Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam Study. Stroke (2008) 1.45
Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke (2008) 1.45
Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care (2009) 1.43
Safety by design: effects of operating room floor marking on the position of surgical devices to promote clean air flow compliance and minimise infection risks. BMJ Qual Saf (2011) 1.43
External validation of a prognostic model predicting time of death after withdrawal of life support in neurocritical patients. Crit Care Med (2012) 1.43
Learning to cross boundaries: the integration of a health network to deliver seamless care. Health Policy (2006) 1.43
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke (2005) 1.42
Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study. Perit Dial Int (2011) 1.40
Methodological quality and publication bias in observational studies on risk of rupture of unruptured intracranial aneurysms. Stroke (2007) 1.40
Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma (2013) 1.40
Ambulatory arterial stiffness index is not associated with magnetic resonance imaging markers of cerebral small vessel disease in lacunar stroke patients. J Clin Hypertens (Greenwich) (2015) 1.38
High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke (2006) 1.37